Reechpharma

We are a San Francisco Bay Area based CRO/CDMO supporting biopharma companies with customized formulations and clinical trial materials manufacturing. Our vision is to improve clinical success through customized formulations! Today, fewer than 5% of drug candidates advance from Phase 1 to clinical approval, but research has consistently shown that the right formulation strategy can increase clinical success rates by 30–40%. Formulations that control solubility, permeability, release rate, stability, scalability and patient acceptability can dramatically reduce false-negative outcomes. We are committed to advancing science-driven, tailored formulations that help innovators reach the clinic faster—and reach patients with better, safer, more effective medicines. Our scientific belief: With the right formulation fit, every drug molecule can achieve clinical success and serve humanity! Our capabilities: Preclinical to post marketed formulations - any dosage, any route, any challenge.* API Characterization * Solubility and compatibility studies of your API vs excipients * Technical Solutions for Solubility and Permeability Challenges * Micronizing by Milling or by creating Amorphous Solid Dispersions via Spray-Drying or HME * Design and development of Preclinical Formulations * Numerous Dosage Forms with a Wide Range of Release Profiles * Preparation of Scalable Prototype Formulations of Animal PK Dosage forms for DMPK, Toxicity, or Efficacy Studies * Analytical Studies of formulations to back up your dosage form with data pertaining to purity, stability, and dissolution profiles.* GLP Formulations for toxicity Assessments * Phase 1 Manufacturing of Clinical Materials